国药控股：国药器械年度营业利润12.49亿元 同比增加2.38%

Core Viewpoint - China National Pharmaceutical Group (国药控股) reported a decrease in revenue but an increase in profit and comprehensive income for its subsidiary China Medical Device Co., indicating a mixed financial performance for the year ending December 31, 2025 [1] Financial Performance - Revenue for China Medical Device Co. reached 74.893 billion yuan, a year-on-year decrease of 2.35% [1] - Operating profit was 1.249 billion yuan, reflecting a year-on-year increase of 2.38% [1] - Comprehensive income attributable to the parent company was 507 million yuan, showing a significant year-on-year increase of 25.64% [1]